Antares Pharma Inc (NASDAQ:ATRS)

2.13
Delayed Data
As of Jul 02
 -0.01 / -0.47%
Today’s Change
1.82
Today|||52-Week Range
3.04
-17.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-4.4M-11.4M-20.5M-35.2M
 
 
 
 
 
Depreciation168.2K231.0K493.3K1.2M
 
 
 
 
 
Total Other Cash Flow1.8M2.1M5.1M6.2M
 
 
 
 
 
Funds From Operations-2.4M-9.1M-14.9M-27.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-451.0K1.4M39.9K-1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-1.9M-10.5M-15.0M-26.3M
 
 
 
 
 
 
InvestingIncrease In Investments-15.1M-30.2M-21.1M0.00
 
 
 
 
Decrease In Investments0.0012.0M24.0M24.0M
 
 
 
 
Capital Expenditures-350.5K-3.3M-2.7M-4.7M
 
 
 
 
 
Fixed Asset Disposal30.0K0.000.00--
 
 
Net Cash Flow Investing-15.6M-21.7M-293.1K18.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale27.3M64.9M2.3M3.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing233.3K28.9K104.3K154.4K
 
 
 
 
 
Net Cash Flow - Financing27.1M64.9M2.2M3.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-26.0K1.1K8.9K-2.6K
 
 
 
 
 
 
Net Change In Cash9.5M32.7M-13.0M-5.0M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account